Поисковый запрос: <.>II=ЕУ12/2019/41/2<.> |
Общее количество найденных документов : 16
Показаны документы с 1 по 16 |
>1.
| Yakovlev P.G. Bladder sparing surgery in high-grade bladder cancer/P. G. Yakovlev, D. A. Klyushin, R. I. Vereshchako // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.160-165
|
>2.
| Tumor-associated redox state in metastatic colorectal cancer/A. P. Burlaka [та ін.] // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.148-152
|
>3.
| The observation of congenital retroperitoneal large size neuroblastoma /I. I. Starchenko [та ін.] // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.179-181
|
>4.
| The impact of maximal strength training on quality of life among women with breast cancer undergoing treatment/R. Cešeiko [та ін.] // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.166-172
|
>5.
| Tajaldeen A. Investigation of dosimetric impact of organ motion in static and dynamic conditions for three stereotactic ablative body radiotherapy techniques: 3D conformal radiotherapy, intensity modulated radiation therapy, and volumetric modulated arc therapy by usi/A. Tajaldeen, S. Alghamdi // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.153-159
|
>6.
| Syvyk A. E. Inducible dominant negative ErbB2 rat spermatogonial line for generation of transgenic rat model and dissecting ERBB2 tyrosine kinase mediated pathways/A. E. Syvyk, T. L. Syvyk // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.95-105
|
>7.
| Proinflammatory effects of photoactivated methylene blue on rat model of Walker 256 carcinosarcoma/M. C. Petrellis [та ін.] // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.112-122
|
>8.
| Prognostic factors in metastatic gastric carcinoma/Kridis W. Ben [та ін.] // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.173-175
|
>9.
| Prepuberal stress and obesity: effects on serum corticosterone, prolactin, testosterone and precancerous prostate lesions in adult rats/D. Herrera-Covarrubias [та ін.] // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.130-137
|
>10.
| Metformin enhances antitumor action of sodium dichloroacetate against glioma C6/D. L. Kolesnik [та ін.] // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.123-129
|
>11.
| Evaluating the role of dithiolane rich fraction of Ferula asafoetida (apiaceae) for its antiproliferative and apoptotic properties: in vitro studies/S. Verma [та ін.] // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.90-94
|
>12.
| Dumanskiy Y. V. The Kі-67 marker for assessing the effectiveness of systemic or regional neoadjuvant polychemotherapy in patients with locally advanced breast cancer/Y. V. Dumanskiy, O. V. Bondar, E. A. Stoliarchuk // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.176-178
|
>13.
| Clinical and pathological prognostic factors in patients with stage III–IVA-B oral squamous cell carcinoma/O. V. Kravets [та ін.] // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.144-147
|
>14.
| Buschke — Lowenstein anal tumor: an ambiguous entity/Kridis W. Ben [та ін.] // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.182-184
|
>15.
| Buchynska L. G. Assessment of HER-2/neu, с-MYC and CCNE1 gene copy number variations and protein expression in endometrial carcinomas/L. G. Buchynska, O. V. Brieiev, N. P. Iurchenko // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.138-143
|
>16.
| Antitumor effects and hematotoxicity of C60-Cis-Pt nanocomplex in mice with Lewis lung carcinoma/S. V. Prylutska [та ін.] // Экспериментальная онкология, 2019. т.Т. 41,N № 2.-С.106-111
|
|